BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 16151647)

  • 1. Temporal evolution of soluble Fas and Fas ligand in patients with orthotopic liver transplantation.
    Wang Y; Liu Y; Han R; Yang J; Zhu Z; Zhang Y; Yao Z; Gao W; Shen Z
    Cytokine; 2008 Mar; 41(3):240-3. PubMed ID: 18267366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decoding the concealed transcriptional signature of the apoptosis-related BCL2 antagonist/killer 1 (BAK1) gene in human malignancies.
    Athanasopoulou K; Adamopoulos PG; Daneva GN; Scorilas A
    Apoptosis; 2022 Dec; 27(11-12):869-882. PubMed ID: 35876934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fas and Fas ligand are highly expressed in lymphocytes from cervical intraepithelial neoplasia and cervical cancer patients: A possible role for immune escaping.
    Contreras-Ochoa CO; Bahena-Román M; López-Díaz LY; Lagunas-Martínez A; Mojica-Cardoso C; Manzo-Merino J; Torres-Poveda K; Madrid-Marina V
    Iran J Basic Med Sci; 2022 Mar; 25(3):383-389. PubMed ID: 35656191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Significance of Circulating Serum Levels of sCD95 and TNF-α in Cytoprotection of Cervical Cancer.
    Agnihotri SK; Kumar B; Jain A; Anjali A; Negi MPS; Sachan R; Bhatt MLB; Tripathi RK; Sachdev M
    Rep Biochem Mol Biol; 2022 Jan; 10(4):711-721. PubMed ID: 35291617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive Markers for Malignant Urothelial Transformation in Balkan Endemic Nephropathy: A Case-Control Study.
    Kocic G; Hadzi-Djokic J; Cukuranovic-Kokoris J; Gajic M; Veljkovic A; Cukuranović R; Basic D; Jovanovic I; Smelcerovic A
    Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33065960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SRSF7 knockdown promotes apoptosis of colon and lung cancer cells.
    Fu Y; Wang Y
    Oncol Lett; 2018 Apr; 15(4):5545-5552. PubMed ID: 29556298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Connecting the speckles: Splicing kinases and their role in tumorigenesis and treatment response.
    Corkery DP; Holly AC; Lahsaee S; Dellaire G
    Nucleus; 2015; 6(4):279-88. PubMed ID: 26098145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter polymorphism of FASL confers protection against female-specific cancers and those of FAS impact the cancers divergently.
    Nallapalle SR; Daripally S; Prasad VT
    Tumour Biol; 2015 Apr; 36(4):2709-24. PubMed ID: 25472583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative splicing in cancer: implications for biology and therapy.
    Chen J; Weiss WA
    Oncogene; 2015 Jan; 34(1):1-14. PubMed ID: 24441040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged.
    David CJ; Manley JL
    Genes Dev; 2010 Nov; 24(21):2343-64. PubMed ID: 21041405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium valproate, a histone deacetylase inhibitor, decreases the secretion of soluble Fas by human osteosarcoma cells and increases their sensitivity to Fas-mediated cell death.
    Yamanegi K; Yamane J; Hata M; Ohyama H; Yamada N; Kato-Kogoe N; Futani H; Nakasho K; Okamura H; Terada N
    J Cancer Res Clin Oncol; 2009 Jul; 135(7):879-89. PubMed ID: 19066961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis induction in Jurkat cells and sCD95 levels in women's sera are related with the risk of developing cervical cancer.
    Aguilar-Lemarroy A; Romero-Ramos JE; Olimon-Andalon V; Hernandez-Flores G; Lerma-Diaz JM; Ortiz-Lazareno PC; Morgan-Villela G; Del Toro-Arreola S; Bravo-Cuellar A; Jave-Suarez LF
    BMC Cancer; 2008 Apr; 8():99. PubMed ID: 18405371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure.
    Perianayagam MC; Murray SL; Balakrishnan VS; Guo D; King AJ; Pereira BJ; Jaber BL
    J Lab Clin Med; 2000 Oct; 136(4):320-7. PubMed ID: 11039853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of soluble FAS, FAS ligand and tumour necrosis factor-alpha in patients with chronic HCV infection.
    Raghuraman S; Abraham P; Daniel HD; Ramakrishna BS; Sridharan G
    J Clin Virol; 2005 Sep; 34(1):63-70. PubMed ID: 16087126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble Fas and soluble Fas L levels in patients with acute pancreatitis.
    Endo S; Inoue Y; Fujino Y; Yamada Y; Sato N; Wakabayashi G; Sakamoto T; Ishikura H; Tanaka T; Inada K; Sato S
    Res Commun Mol Pathol Pharmacol; 2000; 108(3-4):179-86. PubMed ID: 11913710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis in human uterine leiomyomas.
    Martel KM; Ko AC; Christman GM; Stribley JM
    Semin Reprod Med; 2004 May; 22(2):91-103. PubMed ID: 15164304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of Fas mediated apoptosis in preeclampsia.
    Neale DM; Mor G
    J Perinat Med; 2005; 33(6):471-7. PubMed ID: 16318609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble Fas receptor and soluble Fas ligand in the serum of women with uterine tumors.
    Kondera-Anasz Z; Mielczarek-Palacz A; Sikora J
    Apoptosis; 2005 Oct; 10(5):1143-9. PubMed ID: 16151647
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.